Bulletin
Investor Alert

Market Pulse Archives

Sept. 15, 2020, 6:41 a.m. EDT

BioNTech shares jump premarket on news of 375 million euros in German funding for COVID-19 vaccine

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    BioNTech SE ADR (BNTX)
  • X
    Pfizer Inc. (PFE)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Ciara Linnane

BioNTech SE shares /zigman2/quotes/214419716/composite BNTX +14.19% soared 4% in premarket trade Tuesday, after the drug company said it will receive up to 375 million euros ($445.9 million) in funding from the German Federal Ministry of Education and Research to support the accelerated development of a COVID-19 vaccine in collaboration with partner Pfizer Inc. /zigman2/quotes/202877789/composite PFE +6.11% and Fosun Pharma. The effort is one of three programs that the German ministry is funding with up to 750 million euros in total. BioNTech has also achieved five of eight defined milestones in developing a vaccine and has gained approval from the Paul-Ehrlich-Institut, to initiate the German arm of the global Phase 2/3 trial. The company has started recruiting patients on three continents and has enrolled more than 28,000 at sites in the U.S., Brazil, Argentina and Europe. Shares have gained 99% in the year to date, while the S&P 500 /zigman2/quotes/210599714/realtime SPX -2.27% has gained 4.7%.

/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 348.00
+43.24 +14.19%
Volume: 11.03M
Nov. 26, 2021 1:00p
P/E Ratio
10.05
Dividend Yield
N/A
Market Cap
$84.40 billion
Rev. per Employee
$283,276
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 54.00
+3.11 +6.11%
Volume: 66.56M
Nov. 26, 2021 1:10p
P/E Ratio
16.03
Dividend Yield
2.89%
Market Cap
$303.09 billion
Rev. per Employee
$533,860
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,594.62
-106.84 -2.27%
Volume: 2.10B
Nov. 26, 2021 2:12p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.